Atritech Inc.
This article was originally published in Start Up
Executive Summary
Atritech Inc. is developing a minimally invasive device to prevent harmful-sized emboli from exiting the left atrial appendage. It believes that its Watchman filter will be just as effective as warfarin in preventing strokes in AF patients.
You may also be interested in...
AF Ablation: Progress & Promise
Tremendous progress has been made in the field of ablation therapy for atrial fibrillation (AF) over the past several years, and numerous device-based technologies to address this underserved and rapidly growing patient population are under clinical development. Minimally invasive, percutaneous AF ablation has evolved rapidly as well, although the procedure remains very challenging and limited to highly experienced centers.
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.